1-2 of 2
Elmira Boychenko, MD PhD
Close
Sort by
Journal Articles

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Alexander Popov, MD PhD, Barbara Buldini, MD PhD, Paola De Lorenzo, PhD, Silvia Disaro, Tatiana Verzhbitskaya, MD PhD, Liudmila Movchan, PhD, Emanuela Giarin, Egor Shorikov, MD PhD, Annamaria Di Meglio, Grigory Tsaur, MD PhD, Franco Locatelli, MD PhD, Rosanna Parasole, MD, Natalia Miakova, MD PhD, Elmira Boychenko, MD PhD, Konstantin Kondratchik, MD, Olga Aleinikova, MD PhD, Alexander Karachunskiy, MD PhD, Alexander Roumiantsev, MD PhD, Andrea Biondi, MD PhD, Rob Pieters, MDPhDMSc, Maria Grazia Valsecchi, PhD, Larisa Fechina, MD PhD, Giuseppe Basso, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2747.
https://doi.org/10.1182/blood-2019-130210
Published: 2019
Journal Articles

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, Grigory Tsaur, MD PhD, Egor Shorikov, MD PhD, Liudmila Movchan, MD PhD, Mikhail Belevtsev, MD PhD, Anatoly Kustanovich, PhD, Olga Streneva, MD PhD, Olga Khlebnikova, MD, Natalia Myakova, Dmitry Litvinov, MD PhD, Konstantin Kondratchik, MD, Elmira Boychenko, MD PhD, Olga Aleinikova, PhD, Michael Maschan, MD PhD, Alexander Karachunskiy, MD PhD, Larisa Fechina, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1731.
https://doi.org/10.1182/blood.V128.22.1731.1731
Published: 2016